INTRODUCTION: Onabotulinum toxin serotype A (BT-A) is used for a variety of motor and sensory disorders related to abnormal muscle activity. METHODS: We developed a high-resolution rodent model to allow precise determination of the effect of BT-A dose (measured in units) and injectate volume (measured in μl) on the efficacy of the injection and systemic side effects. Dorsiflexion is the best indicator of injected and contralateral muscle function. RESULTS: One month after injection, dorsiflexion torque of BT-A-injected limbs was decreased significantly in all experimental groups compared with saline controls (P < 0.05). Torque was also compared among the BT-A groups, which demonstrated a significant effect of dose (P < 0.001), but no effect of volume (P > 0.2) and no dose × volume interaction (P > 0.3). Similar results were observed for other parameters measured. CONCLUSIONS: These data demonstrate that injection dose and not volume or concentration is the primary determinant of neurotoxin efficacy in a rodent model.
INTRODUCTION: Onabotulinum toxin serotype A (BT-A) is used for a variety of motor and sensory disorders related to abnormal muscle activity. METHODS: We developed a high-resolution rodent model to allow precise determination of the effect of BT-A dose (measured in units) and injectate volume (measured in μl) on the efficacy of the injection and systemic side effects. Dorsiflexion is the best indicator of injected and contralateral muscle function. RESULTS: One month after injection, dorsiflexion torque of BT-A-injected limbs was decreased significantly in all experimental groups compared with saline controls (P < 0.05). Torque was also compared among the BT-A groups, which demonstrated a significant effect of dose (P < 0.001), but no effect of volume (P > 0.2) and no dose × volume interaction (P > 0.3). Similar results were observed for other parameters measured. CONCLUSIONS: These data demonstrate that injection dose and not volume or concentration is the primary determinant of neurotoxin efficacy in a rodent model.
Authors: Markus Naumann; Alastair Carruthers; Jean Carruthers; Sheena K Aurora; Ross Zafonte; Susan Abu-Shakra; Terry Boodhoo; Mary Ann Miller-Messana; George Demos; Lynn James; Frederick Beddingfield; Amanda VanDenburgh; Mary Ann Chapman; Mitchell F Brin Journal: Mov Disord Date: 2010-10-15 Impact factor: 10.338
Authors: Min Dong; Felix Yeh; William H Tepp; Camin Dean; Eric A Johnson; Roger Janz; Edwin R Chapman Journal: Science Date: 2006-03-16 Impact factor: 47.728
Authors: Eric R Hentzen; Michele Lahey; David Peters; Liby Mathew; Ilona A Barash; Jan Fridén; Richard L Lieber Journal: J Physiol Date: 2005-10-20 Impact factor: 5.182
Authors: Carolyn M Eng; Laura H Smallwood; Maria Pia Rainiero; Michele Lahey; Samuel R Ward; Richard L Lieber Journal: J Exp Biol Date: 2008-07 Impact factor: 3.312
Authors: Viviane B Minamoto; Jonah B Hulst; Michael Lim; William J Peace; Shannon N Bremner; Samuel R Ward; Richard L Lieber Journal: Dev Med Child Neurol Date: 2007-12 Impact factor: 5.449
Authors: Jean-Michel Gracies; Mara Lugassy; Donald J Weisz; Michele Vecchio; Steve Flanagan; David M Simpson Journal: Arch Phys Med Rehabil Date: 2009-01 Impact factor: 3.966
Authors: Austin V Stone; Jianjun Ma; Patrick W Whitlock; L Andrew Koman; Thomas L Smith; Beth P Smith; Michael F Callahan Journal: J Orthop Res Date: 2007-12 Impact factor: 3.494
Authors: Megan L Killian; Leonardo M Cavinatto; Samuel R Ward; Necat Havlioglu; Stavros Thomopoulos; Leesa M Galatz Journal: Am J Sports Med Date: 2015-08-21 Impact factor: 6.202
Authors: Samuel R Ward; Viviane B Minamoto; Kentaro P Suzuki; Jonah B Hulst; Shannon N Bremner; Richard L Lieber Journal: Muscle Nerve Date: 2017-06-15 Impact factor: 3.217
Authors: Viviane B Minamoto; Kentaro P Suzuki; Shannon N Bremner; Richard L Lieber; Samuel R Ward Journal: Muscle Nerve Date: 2015-06-30 Impact factor: 3.217
Authors: Leah E Worton; Edith M Gardiner; Ronald Y Kwon; Leah M Downey; Brandon J Ausk; Steven D Bain; Ted S Gross Journal: PLoS One Date: 2018-11-14 Impact factor: 3.240